Tower Research Capital (TRC)’s Processa Pharmaceuticals PCSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505 | Sell |
2,462
-5
| -0.2% | -$1 | ﹤0.01% | 5005 |
|
|
2025
Q1 | $913 | Buy |
2,467
+5
| +0.2% | +$2 | ﹤0.01% | 4803 |
|
|
2024
Q4 | $2.18K | Sell |
2,462
-1,178
| -32% | -$1.04K | ﹤0.01% | 4890 |
|
|
2024
Q3 | $4.99K | Buy |
3,640
+641
| +21% | +$878 | ﹤0.01% | 4351 |
|
|
2024
Q2 | $6.72K | Sell |
2,999
-1,506
| -33% | -$3.37K | ﹤0.01% | 4550 |
|
|
2024
Q1 | $10.7K | Buy |
4,505
+4,445
| +7,408% | +$10.5K | ﹤0.01% | 3671 |
|
|
2023
Q4 | $400 | Sell |
60
-445
| -88% | -$2.97K | ﹤0.01% | 5585 |
|
|
2023
Q3 | $2.52K | Buy |
505
+65
| +15% | +$325 | ﹤0.01% | 5138 |
|
|
2023
Q2 | $4.38K | Sell |
440
-6
| -1% | -$60 | ﹤0.01% | 4931 |
|
|
2023
Q1 | $4K | Buy |
446
+35
| +9% | +$314 | ﹤0.01% | 5098 |
|
|
2022
Q4 | $9K | Buy |
411
+183
| +80% | +$4.01K | ﹤0.01% | 4238 |
|
|
2022
Q3 | $10K | Buy |
228
+157
| +221% | +$6.89K | ﹤0.01% | 4562 |
|
|
2022
Q2 | $4K | Sell |
71
-86
| -55% | -$4.85K | ﹤0.01% | 5242 |
|
|
2022
Q1 | $9K | Buy |
157
+76
| +94% | +$4.36K | ﹤0.01% | 4474 |
|
|
2021
Q4 | $8K | Buy |
+81
| New | +$8K | ﹤0.01% | 4814 |
|
|
2021
Q2 | – | Sell |
-12
| Closed | -$3K | – | 5745 |
|
|
2021
Q1 | $3K | Sell |
12
-55
| -82% | -$13.8K | ﹤0.01% | 4914 |
|
|
2020
Q4 | $9K | Buy |
+67
| New | +$9K | ﹤0.01% | 4394 |
|